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Abstract 
Prostate cancer (PCa) is the most common cancer in men in the United States. Multiparametic magnetic 
resonance imaging (mp-MRI) has been explored by many researchers to targeted prostate biopsies and 
radiation therapy. However, assessment on mp-MRI can be subjective, development of computer-aided 
diagnosis systems to automatically delineate the prostate gland and the intraprostratic lesions (ILs) becomes 
important to facilitate with radiologists in clinical practice. In this paper, we first study the implementation 
of the Mask-RCNN model to segment the prostate and ILs. We trained and evaluated models on 120 patients 
from two different cohorts of patients. We also used 2D U-Net and 3D U-Net as benchmarks to segment 
the prostate and compared the model's performance. The contour variability of ILs using the algorithm was 
also benchmarked against the interobserver variability between two different radiation oncologists on 19 
patients. Our results indicate that the Mask-RCNN model is able to reach state-of-art performance in the 
prostate segmentation and outperforms several competitive baselines in ILs segmentation. 
1. Introduction  
Prostate cancer (PCa) is the most common cancer in men in the United Stated (Smith, Andrews et al. 2018). 
According to the American Cancer Society, 174,650 new cases and 31,620 deaths caused by PCa were 
expected in 2019 (Siegel, Miller et al. 2019). Currently prostate biopsy is the gold standard to identify the 
presence of PCa. Due to the poor resolution of gray-scale ultrasound image, conventional transrectal 
ultrasound (TRUS) guided biopsy has a low detection rates and the rate of false negative can be as high as 
40% (Pallwein et al., 2008), which poses a significant threat on patients and is referred to as a “blind” 
procedure (Ahmed et al., 2009). The advanced technique of MRI-guided biopsy has been introduced and 
reported by several institutes (Beyersdorff et al., 2005; Anastasiadis et al., 2006; Hambrock et al., 2010; 
Schoots et al., 2015) for its potential to improve diagnosis accuracy of biopsy and reduce the number of 
required needle insertion.  
Multi-parametic magnetic resonance imaging (mp-MRI), which combines anatomic T1- and T2-weighted 
imaging (T2WI) with diffusion and perfusion weighted image sequences has been clinically incorporated 
into prostate cancer diagnosis, risk stratification, staging and treatment guidance. Namely, the apparent 
diffusion coefficient (ADC) map is derived from diffusion weighted imaging (DWI), which measures the 
Brownian motion of water molecules in tissue, and depends on many factors such as cell density, size and 
shape. Perfusion- weighted imaging assesses angiogenesis and microvascular vessel wall permeability. It 
is dependent on tumor region, temporal and spatial resolution, and the model itself. The use of mp-MRI has 
been recommended in morphological assessment of the prostate and tumor identification within the gland 
(Ghai and Haider, 2015).  
Automated segmentation of the prostate and screening of prostate cancer from MR images is critical for 
computer-aided clinical diagnosis, treatment planning and prognosis. However, the development of 
automatic algorithms remains challenging in several reasons. First of all, there are large variations in image 
quality caused by several factors at the time of image acquisition (e.g. patient motion, signal-to-noise ratio, 
use of an endorectal coil, Gadolinium enhancement, etc.). Second, the normal anatomy of the prostate is 
highly variable across patients and at different time points; and the boundaries between the prostate and 
surrounding structures (e.g. neurovascular bundles, bladder, rectum, seminal vessels and other soft tissues) 
are not always immediately clear. The prostate also shows a large variation in size and shape among 
different patients due to individual differences and physiological changes. Third, the presence of benign 
conditions such as benign prostatic hyperplasia and prostatitis may mimic the radiographic presentation of 
a malignancy. Contrast and pixel value of MRI also highlight a large variability in both tissue and texture 
information.  
Over the past few years, progress in image segmentation tasks has been exclusively driven by convolutional 
neural network (CNN) based models. Many segmentation models fall into two classes. The first class does 
not rely on the region proposal algorithm. Typical models in this class usually apply an encoder-decoder 
framework (Liou et al., 2014). The encoder network extracts representations of the image, and the decoder 
network reconstructs segmentation mask from the learned image representations produced by the encoder 
network. U-Net (Ronneberger et al., 2015), for instance, is a classic algorithm widely used in biomed- ical 
image segmentation tasks. Another class of models have their underlying fundamentals on region proposals 
such as the Mask-RCNN model, which was firstly developed in 2017 by following the basic ideas of Faster-
RCNN model. It has a broad use in semantic segmentation, object localization and objection instance 
segmentation of natural images and human pose estimation (He et al., 2017) and outperformed all existing 
single-model entries on each task in the 2016 COCO Challenge.  
Technical Significance We trained and evaluated Mask-RCNN models in the first place to perform 
multiple tasks including segmentation of both the prostatic gland and ILs. We proposed a method of training 
for the prostate segmentation to reduce false positives/negatives. Another contribution is that we extended 
2D Mask-RCNN model to be able to generate volumetric segmentation of ILs and output top 5 candidate 
lesions inside the whole prostate.  
Clinical Relevance Though mp-MRI and other image acquisition tools have being im- proved over decades 
to capture structural, cellular, vascular and functional properties of prostate, the large amount of data 
prevents image interpretation, through the prostate de- lineation to ILs localization and segmentation being 
reproducible and efficient (Lee et al., 2009). Furthermore, subjectivity, variations and fatigue (Dosovitskiy 
et al., 2015) among interpreters restricts precise and quantitative measurement of ILs prior to therapeutic 
interventions. In this regard, computer-aided diagnosis systems have been established to help clinicians in 
their clinical practice. The aim of our research of work is to: 1) provide a quantitative assessment framework 
for the prostate and ILs; 2) output highly suspicious lesions that is able to augment clinicians to improve 
accuracy, reduce cost and reduce burnout.  
2. Patient Cohorts  
A total of 120 patients consists of two patient cohorts were studied. Group A came from the SPIE-AAPM-
NCI Prostate MR Gleason Grade Group Challenge (PROSTATEx-2 Challenge), which is a retrospective 
set of prostate MR studies conducted by American Association of Physicists in Medicine (AAPM) along 
with the International Society for Optics and Photonics (SPIE) and the National Cancer Institute (NCI) 
(Litjens et al., 2014). Each patient case of this database is a single examination from a distinct patient. A 
random of 78 patients are selected from this database and all patients have biopsy proved lesion status. The 
images were acquired on two types of Siemens 3T MR scanners, the MAGNETOM Trio and Skyra. Axial 
T2WIs were acquired using a turbo spin echo sequence with a resolution of around 0.5 mm in plane and 
slice thickness of 3.6 mm. Axial DWI sequences were acquired using a single-shot echo planar imaging 
sequence with a resolution of 2 mm in plane and 3.6 mm slice thickness and with diffusion-encoding 
gradients in three directions. Three b-values were acquired (50, 400 and 800 s/mm2), and the ADC map 
was calculated by the scanner software. All images were acquired without an endorectal coil. For group A, 
the prostate gland and IL based on the biopsy marker were contoured by a clinician from our institute.  
Group B: Forty-two patients who underwent mp-MRI scans were collected at our institute. An ultrasound 
guided needle biopsy was performed to confirm the presence of PCa. All examinations were performed 
using a 3T MR scanner (Ingenia; Philips Medical System, Best, the Netherlands). Axial T2WIs were 
obtained using Fast-Spin-Echo (TE/TR: 4389/110 ms, Flip Angle: 90◦) with a resolution of 0.42 mm in 
plane and slice thickness of 2.4 mm. Axial DWIs were obtained (TE/TR: 4000/85 ms, Flip Angle: 90◦) with 
a resolution 1.79 mm in plane and slice thickness of 0.56 mm. The voxel-wise ADC map was constructed 
using two DWIs with two b-values (0, 1000 s/mm2). Sixteen patients from group B had prostate gland 
contoured by a different clinician from group A and all patients had all ILs contoured by three different 
clinicians from our institute.  
In the study of the prostate segmentation, 24 patients were randomly selected from group A and evenly 
divided into validation set and testing set. The rest of 54 patients were used for the training set. Sixteen 
patients from group B served as an independent testing cohort. In the study of ILs segmentation, 45 patients 
from group A and 12 patients from group B were randomly selected into training. Ten patients were selected 
respectively from group A and group B (for group B we selected patients with only one lesion identified) 
for validation. The rest 23 patients from group A and 20 patients from group B were used for the testing 
aim. For the 20 patients from group B, 3 patients have 3 lesions contoured, 8 patients have 2 lesions 
contoured and the rest 9 patients have only one lesion contoured.  
In the study of the prostate segmentation, we used T2WIs only in training, validation and testing since the 
prostate gland can be well defined on the morphological imaging. The long dimension of T2WI was resized 
to be 384, and the short dimension was resized to keep the same width/length ratio as the original one and 
padded by zero to be 384. For ILs segmentation, the combination of T2 and ADC is used as input. The 
ADC map was re-sampled using bi-linear interpolation and rigidly registered to T2WI using an in-house 
developed software. The ILs were identified and contoured based on both T2WI and ADC following the 
criteria of hypointense values on the T2W images and ADC maps. All images were firstly normalized slice 
by slice, and then had the histogram equalized.  
3. Methods  
3.1. Network Architecture  
Region proposal network (RPN) is the backbone architecture used as the first stage in both Faster-RCNN 
and Mask-RCNN and has been proven to be very effective and efficient until now. The purpose of RPN is 
to identify interested objects within a particular image. One popular backbone architecture is ResNet (He 
et al., 2016) and its deep variants (e.g. ResNeXt (Xie et al., 2017)) with different depth layers (50 or 101 
layers) (Dai et al., 2016; Huang et al., 2017; Liu et al., 2017). Another commonly used backbone 
architecture is Feature Pyramid Network (FPN) proposed by (Lin et al., 2017). He et al. explored and 
evaluated different backbones and claimed a ResNet-FPN backbone gained an outstanding performance in 
both prediction accuracy and time efficiency. Inheriting the spirit of Faster- RCNN, Mask-RCNN also 
applies bounding box classification and regression in parallel, where the bounding box classifier calculates 
the probability a proposal containing an object and the regression branch regresses the coordinates of 
proposals to improve localization accuracy. Mask-RCNN differs from Faster-RCNN that it has an 
additional branch (head architecture) to output binary mask for each region of interest (RoI). Mask is 
predicted from each ROI based on the pixel-to-pixel segmentation using a FCN. Mask-RCNN adopts a 
RoIAlign layer to properly align the extracted features with the input.  
 
Figure 1: General Mask-RCNN network architecture used in our paper. Predefined an- chors with different 
scales at one location are shown as purple bounding boxes on the input image. Cubes are represented by 
kernel size × kernel size × number of filters, above branch is used for classification, bottom branch is used 
for segmentation. 
There are a variety of choices of components for the Mask-RCNN model, and we demonstrate our network 
architecture in Figure 1. A 101-layers deep residual network is used as the bottom-up pathway for Feature 
Pyramid Network (FPN) to build pyramid feature maps over the input image and can better extract features 
at multiple scales. A set of anchors are predefined with relative locations and scales and each one binds to 
the feature map with corresponding locations and levels. The pyramid features are passed to a shared 
convolution to generate classes of anchors (background or foreground) and bounding box refinements. 
Anchors are then filtered by the Region Proposal method, where top anchors are selected, overlapped 
anchors are removed, and bounding box refinements are again applied to generate final RoIs (which is also 
called Non-max Suppression). Before running the brunch of RoI classification and bounding box regressor, 
a ROIAlign algorithm is applied to align feature maps with input properly with a fixed size (e.g. 7 × 7) 
using interpolation. The bounding box regressor will again refine the location and bounding box size to 
improve object inclusion. The segmentation branch takes positive RoIs selected by the RoI classifier and 
generates masks for them. Similarly, feature maps are aligned to input with a fixed size (e.g. 28 × 28). 
Based on the proximate prostate and PCa size with respect to the image size, anchor sizes are initiated into 
16, 32, 64, 128, and 256.  
3.2. Evaluation Metrics  
The metrics we used to evaluate the agreement between the predictions and the given ground truth include 
the dice similarity coefficient (DSC), 95 percentile Hausdorff distance (HD), sensitivity, and specificity. 
DSC intends to evaluate how well two binary sets match and a DSC of 1 means the prediction and contoured 
mask are perfectly matched. HD measures how far two subsets within a metric space are from each other. 
HD and DSC work as both boundary and volume metrics to provide a more comprehensive view of 
segmentation accuracy. Sensitivity, also known as the true positive rate (TPR), measures the proportion of 
actual positives that are correctly identified; specificity, also known as the true negative rate (TNR) 
measures the proportion of actual negatives that are correctly identified. We also defined the agreement rate 
to evaluate the degree to which the algorithm segmentation result concur with the segmentation result by 
clinicians. The formulas for those metrics are shown below:  
, 
where ytrue is the ground truth contour, y ̄pred is the model prediction.  
， 
where a and b are points of sets A and B, respectively, and d(a,b) is Euclidean distance between these points. 
95 percentile HD says that 95% of minb∈B d(a,b) is below this amount.  
, 
, 
where for the prostate segmentation, DTP denotes the number of slices detected the prostate, DTN denotes 
the number of slices detected no prostate. TP denotes the total number of slices truly containing the prostate, 
TN denotes the total number of slices truly containing no prostate. For ILs segmentation, DTP denotes the 
number of detected true positives (detected lesion pixels), DTN denotes the number of detected true 
negatives (detected background pixels), and TP denotes the total number of positives (total lesion pixels), 
TN denotes the total number of negatives (total background pixels). Pixels are counted inside the whole 
prostate.  
， 
where DTP denotes the number of predicted lesions having DSC greater than 0.2 with lesions contoured by 
clinicians, TP denotes the number of lesions contoured by clinicians.  
3.3. Implementation  
Our implementation of Mask-RCNN model is based on an existing development by Matter- port Inc., which 
is based on the open-source libraries Tensorflow and Keras Abdulla (2017). All training, validation and 
testing phase was conducted on the same workstation equipped with a NVIDIA Quadro P5000 GPU. We 
trained the network with Adam optimizer Kingma and Ba (2014). The learning rate was initiated to be 
0.0001, and β1 equals to 0.9, β2 equals to 0.99. The models were trained for 240,000 iterations; model 
parameters were saved every 2000 iterations.  
As the resolution and field of view (FOV) are different among different MRI scans, several data 
augmentation options were applied during the training phase, including flipping up to down, flipping left 
to right, adding random noise, blurring by Gaussian kernel, rotation, horizontal and vertical translation and 
scaling. With respect to prostate segmentation, flipping left to right was applied. Gaussian noise with a 
uniform distributed sigma between 0.05 and 0.1 was added to image, and Gaussian kernel with a uniform 
distributed sigma between 0.8 and 1.3 was applied to blurring image. Rotation angle lied in the range of -
20◦ to 20◦. Image was translated at a random value between 0 and 50 pixels in either the vertical direction 
or horizontal direction. With respect to lesion segmentation, the augmentation methods mentioned above 
were all applied, but rotation angle was in the range from -80◦ to 80◦ and translation was in the range from 
0 to 20 pixels. All augmentation options were randomly applied with the probability of 0.5. Models were 
trained using a batch size of one. DSC was calculated on the validation set which didn’t participate in the 
training phase, and the iteration with the highest DSC was selected as our model. To ensure there is no over 
fitting and selection bias, we tested the model using the testing set.  
3.4. Extension of model to 3D space  
Many algorithms were developed based on 3D CNN and they claimed it is more effective in exploring 
volumetric structure. However, we found it difficult to direct extend Mask-RCNN model into 3D 
architecture as it requires large amount of RPNs and is memory consuming and time consuming to train. 
We, on the other hand, proposed a method to extend the model to obtain volumetric segmentation results.  
Prostate segmentation We found 2D Mask-RCNN usually introduces false positive in superior/inferior 
slices from the prostate gland (bladder and rectum) and false negative in apex and base of the prostate. To 
train the model for prostate segmentation, an average square area of prostate was estimated based on the 
training set. For images without a prostate contour, this area was masked and labeled as ’none-prostate’. 
Images with a prostate contour were masked by the closing contour and labeled as ’prostate’. While in the 
validation and testing phase, if multiple detections were obtained, we selected the one with the highest score 
to determine if the current image contained a prostate. We found this way largely decreased the false 
positive/negative rate.  
Lesion segmentation We extended the Mask-RCNN model to multi-focal PCa detection and picked top 5 
suspicious lesions which is consistent with the procedure of MRI guided prostate biopsy. Several bounding 
boxes could be detected on the same image for possible localization and segmentation of the ILs. In order 
to obtain the final detections, we proposed a method to localize the ILs in a recursive manner in the 3D 
space. Firstly we performed a step similar to non-maxium suppression in object detection, but we calculated 
the DSC between contours and unified two contours and their bounding box when DSC was greater than 
0.5 for each slice. We then selected the top detection with the highest prediction score from all detections 
within the patient, and then traversed the detection to its adjacent slices whether they were correlated with 
the top detection. Correlation was determined by the adjacent lesion prediction score and the DSC with the 
top detection. And two cut off thresholds were fine-tuned on the validation set for the prediction score and 
DSC. In our experiment, the thresholds of prediction score and DSC were 0.7 and 0.41. The adjacent lesion 
was then regarded as the top lesion and we recursively traversed all slices to determine a 3D lesion. Finally 
we eliminated the top 3D lesion from all detections and identified the next top 2 to top 5 lesions following 
the same steps.  
4. Results  
Prostate segmentation Results of prostate segmentation are shown in Table 1. DSC and 95 percentile HD 
is calculated in the 3D space, while true positives and true negatives are counted slice by slice from all 
patients. We selected the model that achieved the highest DSC from the validation set and performed testing 
using both public data and our own data. DSC, 95 HD, TPR and TNR are 0.86 ± 0.04, 6.19 ± 2.38 (mm), 
0.95 and 0.87 respectively using PROSTATEx-2 Challenge dataset, and are 0.82 ± 0.05. 8.94 ± 4.09 (mm), 
0.95 and 0.90, respectively using our own data. Figure 2 shows the prostate segmentation results on T2WI 
by clinician and the algorithm.  
ILs detection and segmentation Results of ILs detection and segmentation are shown in Table 2. The 
validation set has 20 patients/lesions, 10 patients from the PROSTATEx-2 Challenge dataset and 10 patients 
from our institute with only one lesion identified and contoured. The agreement is 80%, DSC is 0.46 ± 0.20. 
The testing set has 43 patients and 57 lesions, 23 patients from the PROSTATEx-2 Challenge dataset with 
only one lesion contoured and 20 patients from our institute with multiple lesions contoured. For patients 
have multiple lesions identified, three patients are identified with three lesions, two of them are detected 
with two lesions, one of them are detected with one lesion; eight patients have two lesions identified, three 
of them are detected both. The agreement is 77%, DSC is 0.46 ± 0.20. Figure 3 shows the ILs segmentation 
results on T2WI by clinician and the algorithm.  
Comparison with U-net To give a more comprehensive and fair evaluation of the perfor- mance of the 
Mask-RCNN, we trained a 2D U-Net as well as a 3D U-Net and calculated the DSC on the prostate contours 
using the same 12 testing patients in prostate segmentation. DSC was calculated to be 0.85±0.03 using 2D 
U-Net and 0.83±0.07 using 3D U-Net.  
Table 1. The result of prostate segmentation by Mask-RCNN 
 DSC 95 HD Sens.  Spec. 
Validation (12) 0.88±0.04  6.05±2.39  0.93 0.98 
Testing (12) 0.86±0.04  6.19±2.38  0.95 0.85 
Testing with own patients (16) 0.82±0.05 8.94±4.09  0.95 0.90 
 
 
Figure 2: Prostate segmentation result on three slices of T2WI from one patient. Ground truth by the 
clinician (top rows) is shown with prostate contour and bounding box; Mask- RCNN prediction (bottom 
rows) is shown with bounding box, prostate contour as well as prediction class and score.  
 Figure 3: Lesion segmentation on two continuous slices of one patient from our institute with two lesion 
identified and contoured (green and red) on T2WI. Ground truth by the clinician (left column) is shown 
with lesion contour and bounding box; prediction of two agreed candidate lesions by the Mask-RCNN 
(right column) is shown with bounding box, lesion contour as well as prediction class and score.  
Table 3. Lesion detection and segmentation results 
 DSC of 
detection 
Agreement Sens. Spec. 
Validation: 10 public 
patients + 10 own 
patients (20 lesions) 
0.46 ± 0.20 80% 0.50 ± 0.22 0.97 ± 0.01 
Testing: 23 public 
patients + 20 own 
patients (57 lesions) 
0.44 ± 0.20 77% 0.46 ± 0.22 0.97 ± 0.02 
 
5. Discussion and Related Work  
5.1. Literature Review  
Conventional research applied classic machine learning and statistical graph models for the problem of the 
prostate and ILs segmentation. The study of neural network based models has only been developed in recent 
3 years and still has a long way to go. We performed a literature review to provide a systematic overview 
over publications and assessed their experiment evaluation set up and results.  
 
Publication Task Method Result Evaluation 
(Tian, Liu et al. 
2016) 
Prostate 
segmentation 
Graph cut DSC = 87.0±3.2% 
 
MICCAI 2012 
Promise12 
challenge 
(Mahapatra and 
Buhmann 2014) 
Prostate 
segmentation 
Superpixel + 
Random forests 
(RF) + Graph cut 
DSC = 0.81 MICCAI 2012 
Promise12 
challenge 
(Guo, Gao et al. 
2016) 
Prostate 
segmentation 
stacked sparse auto-
encoder (SSAE) + 
deformable 
segmentation 
DSC= 0.871±0.042 66 T2-weighted 
MR images 
(Milletari, Navab 
et al. 2016) 
Prostate 
segmentation 
V-Net + Dice-based 
loss  
DSC = 0.869 ± 0.033  Trained with 50 
MRI volumes 
Test with 30 MRI 
scans 
(Zhu et al., 2017)  
 
Prostate 
segmentation 
Deeply-Supervised 
CNN  
 
DSC = 0.885 Trained with 77 
patients 
Test with 4 
patients 
(Yu, Yang et al. 
2017) 
Prostate 
segmentation 
Volumetric 
convolutional 
neural network 
(ConvNet) with 
mixed residual 
connections 
 
DSC = 89.43% MICCAI 2012 
Promise12 
challenge 
(Toth and 
Madabhushi 2012) 
Prostate 
segmentation 
landmark-free 
AAM (MFLAAM) 
DSC = 88% ± 5% 
 
Test with 108 
studies 
(Liao, Gao et al. 
2013) 
Prostate 
segmentation 
Stacked ISA + SL DSC = 86.7 ± 2.2 30 prostate T2 MR 
images 
(Vincent, Guillard 
et al. 2012) 
Prostate 
segmentation 
Active Appearance 
Models (AAM)  
DSC = 0.88 ± 0.03 MICCAI 2012 
Promise12 
challenge 
(Klein, Van Der 
Heide et al. 2008) 
 
Prostate 
segmentation atlas matching 
 
median DSC varied 
between 0.85 and 
0.88 
leave‐one‐out test 
with 50 clinical 
scans 
(Li, Li et al. 2013) Prostate 
segmentation 
random walker DSC = 80.7±5.1% 30 dicom volumes 
of MR images 
(Kohl, Bonekamp 
et al. 2017) 
 
ILs 
Segmentation 
Adversarial 
Networks  
DSC = 0.41 ± 0.28  
Sens. = 0.55 ± 0.36   
Spec. = 0.98 ± 0.14  
four-fold cross-
validation on 55 
patients with 
aggressive tumor 
lesions 
(Cameron, 
Khalvati et al. 
2016) 
 
ILs Detection MAPS 
(Morphology, 
Asymmetry,Physiol
ogy, and Size) 
model 
ACC = 87%±1% 
Sens. = 86%±3% 
Spec. = 88%±1% 
13 patients 
(Chung, Khalvati 
et al. 2015) 
 
ILs 
Segmentation 
Radiomics-driven 
CRF 
Sens. = 71.47% 
Spec.= 91.93% 
Acc. = 91.17% 
DSC = 39.13% 
20 patients 
(Artan, Haider et 
al. 2010) 
 
ILs 
Segmentation 
Cost-sensitive 
SVM+CRF 
Sens. = 0.84±0.19 
Spec. = 0.48±0.22 
DSC = 0.35±0.18 
21 patients 
(Artan, Haider et 
al. 2010) 
 
ILs 
Localization 
random walker Sens. = 0.51  
jakkard  = 0.44  
10 patients 
(Artan, Haider et 
al. 2010) 
 
ILs 
Segmentation 
RW Sens. = 0.62±0.23 
Spec. = 0.89±0.10 
DSC = 0.57±0.21 
16 patients with 
lesions in 
peripheral zone 
 
(Ozer, Haider et al. 
2009) 
 
ILs 
Segmentation 
Relevance Vector 
Machine 
Spec. = 0.78 
Sens. = 0.74 
DSC 0.48 
20 patients 
(Artan, Langer et 
al. 2009) 
 
ILs 
Segmentation 
Cost-sensitive CRF Sens. = 0.73±0.25 10 patients with 
lesions only on 
peripheral zone  
Spec. = 0.75±0.13 
Acc. = 0.71±0.18 
DSC = 0.45±0.28 
(Liu, Langer et al. 
2009) 
 
ILs 
Segmentation 
fuzzy MRFs Spec. = 89.58% 
Sens. = 87.50% 
Acc. = 89.38% 
DSC = 0.6222 
11 patients 
In this study, we provided a fair evaluation using another patient cohort from our institute to test the 
algorithm performance. For the prostate segmentation, the validation and testing result shows promising 
prostate segmentation results using Mask-RCNN on the PROSTATEx-2 Challenge dataset. When using 
our own data as an independent testing cohort, we observed a slightly decreased performance in DSC of 
the model as shown in Table 1, while sensitivity and specificity remain equivalent ti the public dataset. We 
conjecture that it is most likely due to the variability of prostate delineation from a different observer. Other 
causes may be the variation of image quality acquired on a different scanner from the training dataset as 
well as small size of dataset. While U-Net is a more elegant fully convolutional network (FCN), it takes the 
whole image as receptive field for segmentation. Mask-RCNN differs from this kind of segmentation 
models in that it is based on RPN, which firstly select ROIs and then perform pixel-to-pixel segmentation 
using FCN on the selected ROI. We provide a more fair comparison between U-Net and Mask-RCNN using 
the same 12 testing patients from the PROSTATEx-2 Challenge dataset. We compared the DSC calculated 
by 2D and 3D U-Net with that by the Mask-RCNN, and concluded that Mask-RCNN outperformed slightly 
both of the 2D and 3D U-Net on prostate segmentation. Mask-RCNN should work better in lesion 
segmentation than FCN in that it detects possible lesion patches first instead of a direct pixel prediction, 
which makes it able to output a more similar lesion contour to clinician’s contour.  
The segmentation of ILs is challenging due to the strong tissue heterogeneities of the prostate and the subtle 
tumor appearance, leading to large intra- and inter-rater variability in the ground truth. We firstly explored 
contour differences between two radiation oncologists on same lesions from the same 19 patients and DSC 
is measured to be 0.67 ± 0.21. It proved high inter-observer variability in defining IL boundaries with 
trained clinicians. Most researchers evaluated their algorithms with less 20 clinical scans, and some focused 
on lesions in peripheral zone only (Liu et al., 2009; Artan et al., 2009, 2010c), where we validated and 
tested our algorithm using 63 clinical scans from both public and own patients and segment volumetric 
lesions inside the whole prostate. As far as we know, the highest performance is achieved by Liu et al. with 
DSC = 0.6222, Sens. = 87.50%, Spec. = 89.58%. However, the study tested a small cohort of 11 patients 
and limited to the lesions in peripheral zone only. To our best knowledge, there is only one study applying 
the neural network based model or ILs segmentation (Kohl et al., 2017) with DSC = 0.41 ± 0.28, Sens. = 
0.55 ± 0.36, Spec. = 0.98 ± 0.14, but they performed evaluation only on MRI slices with aggressive PCa 
only. Similar to (Kohl et al., 2017), we achieved relative low sensitivity and high specificity compared to 
classic graph models. We assumed there are two reasons: 1) sensitivity and specificity are calculated based 
on the whole prostate volume instead of a single MRI slice, which leads to the high specificity; 2) classic 
graphic model predicts lots of false positives, while our algorithm predicts lesions with more reasonable 
size and shape.  
In conclusion, our framework of research is highly consistent with several clinical proce- dures. It is able 
to work as an end-to-end system to first delineate the prostate gland automatically and prospect for five 
highly suspicious volumetric lesions inside the whole prostate. The results indicate there is a good 
agreement between model’s selections and clinician’s contours, which reveals its capacity in facilitating 
clinicians in diagnosis, MRI guided biopsy, focal therapy or radiation therapy. It also has huge potential to 
augment clinicians to improve diagnosis accuracy, reduce labour cost and reduce burnout.  
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